Logo image of 1ELX.MI

ESTEE LAUDER COMPANIES-CL A (1ELX.MI) Stock Fundamental Analysis

Europe - BIT:1ELX - US5184391044 - Common Stock

84.8 EUR
+6.8 (+8.72%)
Last: 10/17/2025, 7:00:00 PM
Fundamental Rating

3

1ELX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 13 industry peers in the Personal Care Products industry. 1ELX may be in some trouble as it scores bad on both profitability and health. 1ELX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year 1ELX was profitable.
In the past year 1ELX had a positive cash flow from operations.
Of the past 5 years 1ELX 4 years were profitable.
In the past 5 years 1ELX always reported a positive cash flow from operatings.
1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCF1ELX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B 3B

1.2 Ratios

With a Return On Assets value of -5.70%, 1ELX is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -29.31%, 1ELX is doing worse than 92.31% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.17%, 1ELX is doing worse than 76.92% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1ELX is significantly below the industry average of 12.37%.
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROIC 4.17%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
1ELX.MI Yearly ROA, ROE, ROIC1ELX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

1ELX has a Operating Margin of 7.94%. This is in the lower half of the industry: 1ELX underperforms 76.92% of its industry peers.
In the last couple of years the Operating Margin of 1ELX has declined.
With a decent Gross Margin value of 73.96%, 1ELX is doing good in the industry, outperforming 76.92% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ELX has remained more or less at the same level.
Industry RankSector Rank
OM 7.94%
PM (TTM) N/A
GM 73.96%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
1ELX.MI Yearly Profit, Operating, Gross Margins1ELX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

3

2. Health

2.1 Basic Checks

1ELX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
1ELX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1ELX has been reduced compared to 5 years ago.
The debt/assets ratio for 1ELX is higher compared to a year ago.
1ELX.MI Yearly Shares Outstanding1ELX.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ELX.MI Yearly Total Debt VS Total Assets1ELX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

1ELX has an Altman-Z score of 3.17. This indicates that 1ELX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.17, 1ELX is in line with its industry, outperforming 46.15% of the companies in the same industry.
The Debt to FCF ratio of 1ELX is 10.92, which is on the high side as it means it would take 1ELX, 10.92 years of fcf income to pay off all of its debts.
1ELX has a Debt to FCF ratio of 10.92. This is in the lower half of the industry: 1ELX underperforms 76.92% of its industry peers.
1ELX has a Debt/Equity ratio of 1.89. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.89, 1ELX is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Altman-Z 3.17
ROIC/WACC0.56
WACC7.44%
1ELX.MI Yearly LT Debt VS Equity VS FCF1ELX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

1ELX has a Current Ratio of 1.30. This is a normal value and indicates that 1ELX is financially healthy and should not expect problems in meeting its short term obligations.
1ELX has a better Current ratio (1.30) than 61.54% of its industry peers.
A Quick Ratio of 0.92 indicates that 1ELX may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.92, 1ELX is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.92
1ELX.MI Yearly Current Assets VS Current Liabilites1ELX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

4

3. Growth

3.1 Past

1ELX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.31%.
Measured over the past years, 1ELX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -18.22% on average per year.
1ELX shows a decrease in Revenue. In the last year, the revenue decreased by -8.24%.
The Revenue has been growing slightly by 0.04% on average over the past years.
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%

3.2 Future

Based on estimates for the next years, 1ELX will show a very strong growth in Earnings Per Share. The EPS will grow by 27.05% on average per year.
The Revenue is expected to grow by 2.99% on average over the next years.
EPS Next Y41.68%
EPS Next 2Y40.83%
EPS Next 3Y35.52%
EPS Next 5Y27.05%
Revenue Next Year3.06%
Revenue Next 2Y3.64%
Revenue Next 3Y3.92%
Revenue Next 5Y2.99%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1ELX.MI Yearly Revenue VS Estimates1ELX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
1ELX.MI Yearly EPS VS Estimates1ELX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

1ELX is valuated quite expensively with a Price/Earnings ratio of 66.25.
Based on the Price/Earnings ratio, 1ELX is valued more expensive than 84.62% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1ELX to the average of the S&P500 Index (27.42), we can say 1ELX is valued expensively.
The Price/Forward Earnings ratio is 46.61, which means the current valuation is very expensive for 1ELX.
Based on the Price/Forward Earnings ratio, 1ELX is valued more expensive than 84.62% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 1ELX to the average of the S&P500 Index (22.94), we can say 1ELX is valued expensively.
Industry RankSector Rank
PE 66.25
Fwd PE 46.61
1ELX.MI Price Earnings VS Forward Price Earnings1ELX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ELX is valued expensively inside the industry as 92.31% of the companies are valued cheaper.
Based on the Price/Free Cash Flow ratio, 1ELX is valued a bit more expensive than 69.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 53.28
EV/EBITDA 20.39
1ELX.MI Per share data1ELX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as 1ELX's earnings are expected to grow with 35.52% in the coming years.
PEG (NY)1.59
PEG (5Y)N/A
EPS Next 2Y40.83%
EPS Next 3Y35.52%

2

5. Dividend

5.1 Amount

1ELX has a Yearly Dividend Yield of 1.45%.
Compared to an average industry Dividend Yield of 2.56, 1ELX is paying slightly less dividend.
1ELX's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 1.45%

5.2 History

The dividend of 1ELX has a limited annual growth rate of 4.31%.
Dividend Growth(5Y)4.31%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

1ELX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
1ELX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-54.55%
EPS Next 2Y40.83%
EPS Next 3Y35.52%
1ELX.MI Yearly Income VS Free CF VS Dividend1ELX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

ESTEE LAUDER COMPANIES-CL A

BIT:1ELX (10/17/2025, 7:00:00 PM)

84.8

+6.8 (+8.72%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-20 2025-08-20/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners95.71%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap30.56B
Analysts69.44
Price Target77.43 (-8.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.45%
Yearly Dividend1.47
Dividend Growth(5Y)4.31%
DP-54.55%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.72%
Min EPS beat(2)0.44%
Max EPS beat(2)99.01%
EPS beat(4)4
Avg EPS beat(4)57.77%
Min EPS beat(4)0.44%
Max EPS beat(4)99.01%
EPS beat(8)8
Avg EPS beat(8)83.43%
EPS beat(12)11
Avg EPS beat(12)80.65%
EPS beat(16)15
Avg EPS beat(16)63.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.31%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)-2.01%
Revenue beat(4)0
Avg Revenue beat(4)-2.46%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)-2.01%
Revenue beat(8)0
Avg Revenue beat(8)-2.21%
Revenue beat(12)1
Avg Revenue beat(12)-1.91%
Revenue beat(16)3
Avg Revenue beat(16)-1.8%
PT rev (1m)6.64%
PT rev (3m)11.74%
EPS NQ rev (1m)1.32%
EPS NQ rev (3m)-24.69%
EPS NY rev (1m)-4.65%
EPS NY rev (3m)-7.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.08%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)1.23%
Valuation
Industry RankSector Rank
PE 66.25
Fwd PE 46.61
P/S 2.49
P/FCF 53.28
P/OCF 28.06
P/B 9.24
P/tB N/A
EV/EBITDA 20.39
EPS(TTM)1.28
EY1.51%
EPS(NY)1.82
Fwd EY2.15%
FCF(TTM)1.59
FCFY1.88%
OCF(TTM)3.02
OCFY3.56%
SpS34.03
BVpS9.18
TBVpS-4.82
PEG (NY)1.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.7%
ROE -29.31%
ROCE 7.86%
ROIC 4.17%
ROICexc 5.22%
ROICexgc 10.68%
OM 7.94%
PM (TTM) N/A
GM 73.96%
FCFM 4.68%
ROA(3y)0.13%
ROA(5y)4.98%
ROE(3y)-1.32%
ROE(5y)17.24%
ROIC(3y)4.98%
ROIC(5y)7.4%
ROICexc(3y)6.37%
ROICexc(5y)9.94%
ROICexgc(3y)15.14%
ROICexgc(5y)22.74%
ROCE(3y)9.4%
ROCE(5y)13.97%
ROICexcg growth 3Y-33.25%
ROICexcg growth 5Y-18.06%
ROICexc growth 3Y-32.16%
ROICexc growth 5Y-18.64%
OM growth 3Y-26.29%
OM growth 5Y-11.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-0.3%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 1.89
Debt/FCF 10.92
Debt/EBITDA 3.72
Cap/Depr 72.62%
Cap/Sales 4.2%
Interest Coverage 3.22
Cash Conversion 64.7%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.92
Altman-Z 3.17
F-Score4
WACC7.44%
ROIC/WACC0.56
Cap/Depr(3y)208.69%
Cap/Depr(5y)173.4%
Cap/Sales(3y)10.24%
Cap/Sales(5y)8.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.31%
EPS 3Y-40.77%
EPS 5Y-18.22%
EPS Q2Q%-85.94%
EPS Next Y41.68%
EPS Next 2Y40.83%
EPS Next 3Y35.52%
EPS Next 5Y27.05%
Revenue 1Y (TTM)-8.24%
Revenue growth 3Y-6.88%
Revenue growth 5Y0.04%
Sales Q2Q%-11.96%
Revenue Next Year3.06%
Revenue Next 2Y3.64%
Revenue Next 3Y3.92%
Revenue Next 5Y2.99%
EBIT growth 1Y-27.35%
EBIT growth 3Y-31.36%
EBIT growth 5Y-11.51%
EBIT Next Year102.81%
EBIT Next 3Y38.15%
EBIT Next 5Y28.47%
FCF growth 1Y-53.5%
FCF growth 3Y-30.55%
FCF growth 5Y-16.56%
OCF growth 1Y-46.1%
OCF growth 3Y-25.21%
OCF growth 5Y-11.02%